MARCOS
GONZÁLEZ DÍAZ
Investigador en el periodo 1993-2023
Universitat Autònoma de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (10)
2022
-
A gene expression assay based on chronic lymphocytic leukemia activation in the microenvironment to predict progression
Blood Advances, Vol. 6, Núm. 21, pp. 5763-5773
2018
-
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia - Update on methodological approaches and results interpretation
Leukemia, Vol. 32, Núm. 5, pp. 1070-1080
-
Focal adhesion genes refine the intermediate-risk cytogenetic classification of acute myeloid leukemia
Cancers, Vol. 10, Núm. 11
2017
-
NEDD 9 an independent good prognostic factor in intermediaterisk acute myeloid leukemia patients
Oncotarget, Vol. 8, Núm. 44, pp. 76003-76014
2016
-
Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations
Oncotarget, Vol. 7, Núm. 49, pp. 80916-80924
2015
-
Serum ferritin as prognostic marker in classical Hodgkin lymphoma treated with ABVD-based therapy
Leukemia and Lymphoma, Vol. 56, Núm. 11, pp. 3096-3102
2014
-
Long-term outcome and prognostic factors of unrelated cord blood transplantation in children with haematological malignancies: A retrospective study using the Spanish Working Party for BMT in Children (GETMON) database
Bone Marrow Transplantation, Vol. 49, Núm. 6, pp. 767-772
2011
-
Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy
Haematologica, Vol. 96, Núm. 10, pp. 1470-1477